Novartis CEO Vas Narasimhan faces a heap of burning questions — but so far offers no public answers

Novartis new CEO Vas Narasimhan is facing a drumbeat of ominous news as the pharma giant tries to steer through a global controversy about its $1.2 million in payments to President Donald Trump’s personal lawyer Michael Cohen.